BioBridges
Bridging Resourcing Gaps
Mark Bouck, Chairman and CEO
Life Sciences Consulting
Life sciences consulting is a specialized advisory discipline supporting pharmaceutical, biotechnology, and medical device organizations in strategy, regulatory compliance, clinical development, and commercialization. It integrates scientific expertise with business insight to accelerate innovation, optimize operations, and navigate complex healthcare ecosystems, ensuring evidence-based decision-making across research, development, and market access globally.
Solutions
Bringing life sciences innovations to market is a long journey, requiring brilliant minds handling diverse roles and responsibilities. The path from discovery to approval is filled with rigorous testing and unexpected setbacks. Here, specialized expertise is crucial for scientists driving breakthroughs and for the patients whose lives depend on them.
State of Industry
The Transformative Impact of Life Science Consultants
The life sciences sector—including pharmaceuticals, biotechnology, medical devices, and related health technologies—continues to drive innovation, advancing scientific frontiers to enhance human health. Within this, Top companies in life science consulting play a pivotal role, providing specialized expertise and strategic support to help organizations navigate complexity, accelerate development, and achieve their goals. The life science consulting industry is marked by strong growth, the rapid expansion of service capabilities, and an increasing integration of advanced technologies to address clients' evolving needs.
Deep Dive
Choosing Life Science Consulting That Preserves Development Discipline
Biotechnology companies rarely run into trouble because the underlying science is weak. More often, the challenge is organizational. A company may need regulatory expertise during one stage of development, deeper clinical oversight a few months later and then additional support around medical writing, pharmacovigilance or quality systems as the program advances. For many biotech firms, especially emerging companies, building permanent teams around every specialized function simply is not practical.
Leadership Perspective
Parexel
Redefining Global Clinical Trials Through Strategic Innovation
Jessica M. Shepherd, MBA, Senior Director, Solution Consulting
Balancing strategic precision with patient-focused outcomes, Jessica M. Shepherd crafts innovative solutions, redefining the global clinical research landscape.
Solutions
Pratico Consulting
Integrating Science and Technology for Consistent Research Outcomes
Gregory Purnsley, Managing Principal
There are numerous factors which contribute to success in life sciences research. Two key factors depend on how effective scientific rigor and advanced technology come together to support clinical development. Within pharmaceutical, biotechnology, and research, departments typically operate at one end of the spectrum, specializing in their function.
State of Industry
Consulting in Biotechnology: Navigating Complexity for Sustainable Development
In today’s evolving life sciences landscape, biotechnology consulting has emerged as a critical enabler for organizations seeking to translate scientific discovery into commercially viable solutions. Companies operating in this space face complex regulatory frameworks, significant research costs, and the ongoing need to align innovation with market demand. Consulting services provide structured guidance that bridges scientific expertise with business strategy, allowing organizations to navigate uncertainty with greater clarity and confidence.
Deep Dive
Bridging Science and Scale: Rethinking Financial Leadership in Life Sciences
Life science companies often begin with strong scientific conviction yet limited business infrastructure. Founders are equipped to advance research, validate hypotheses and build technical teams, but the transition into a functioning enterprise introduces pressures that extend beyond the lab. Financial planning, workforce structuring and regulatory alignment begin to shape outcomes as much as the science itself. This shift exposes a persistent gap: the ability to translate innovation into a financially viable, fundable and scalable business.
Leadership Perspective
Alkermes
Optimizing Alkermes' R&D Model for Success
Craig Hopkinson, M.D., CMO and Head of Clinical Development and Medical Affairs
Dr. Hopkinson has over 20 years of experience in the biopharmaceutical industry, building and leading clinical development organizations and medical affairs groups. He has led multidisciplinary development teams in neuroscience, oncology, gastroenterology, infectious diseases, cardiovascular conditions, inflammation, genetic diseases, hematology, and neurodegenerative diseases and has extensive knowledge of clinical study design and the regulatory landscape. In his current role, he leads Alkermes' Discovery, Pharmaceutical Development, Early Stage Clinical Development, Late Stage Clinical Development, Regulatory Affairs, Clinical Operations, Project Management, and Medical Affairs functions. He is also responsible for the strategic development and execution of clinical development programs for Alkermes' pipeline of drug candidates.
Solutions
Murdock Martell
The Business Layer Behind Life Sciences Breakthroughs
Claire Martell, Co-founder, CEO and President
Scientific innovation slows not in discovery, but in execution, when early-stage companies must build financial and operational structure to function as businesses. Founders, typically grounded in science, enter this phase without systems to manage funding, compliance and team expansion at scale.
State of Industry
Advanced CFO Services: Improving Life Science Financial Coordination
Life science outsourced CFO services operate within an industry environment where scientific innovation, regulatory complexity, and capital intensity intersect with long development timelines and highly specialized operational structures. Financial leadership in life sciences extends well beyond accounting supervision or budget management. Organizations involved in biotechnology, pharmaceuticals, medical devices, diagnostics, and clinical research require financial strategies capable of supporting research investment, regulatory milestones, intellectual property planning, and commercialization preparation simultaneously. Outsourced CFO services function as strategic financial partners that help organizations manage growth, investor expectations, operational planning, and compliance obligations while allowing scientific teams to remain focused on development and innovation activities.
Deep Dive
Bridging Science and Scale: Rethinking Financial Leadership in Life Sciences
Life science companies often begin with strong scientific conviction yet limited business infrastructure. Founders are equipped to advance research, validate hypotheses and build technical teams, but the transition into a functioning enterprise introduces pressures that extend beyond the lab. Financial planning, workforce structuring and regulatory alignment begin to shape outcomes as much as the science itself. This shift exposes a persistent gap: the ability to translate innovation into a financially viable, fundable and scalable business.
Leadership Perspective
JRS PHARMA
Why It's Challenging to attract and Retain Employees?
Mike Cleary, VP of Finance and Administration
As a VP of Finance and Administration, Mike Cleary oversees finance, IT, quality, and marketing, which allows him to keep an eye on both internal aspects of the company as well as customerfacing things with quality and marketing. He is an accomplished finance professional with a diverse background in CPG and manufacturing industries.
